Review
Open access
Oct 2026
Intratumoral Immunotherapy—The Future of Treating Merkel Cell Carcinoma?
Merkel cell carcinoma (MCC) represents a rare but highly aggressive neuroendocrine skin cancer with limited systemic therapy options for patients who fail or are ineligible for immune checkpoint inhibitors (ICIs). Intratumoral (IT) immunotherapy has emerged as a promising strategy, leveraging the accessibility of tumor...
Nayonika Pande, Justin C. Moser, Sanjay Chandrasekaran et al.
· Cancers · 0 citations